Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to presentation of Bravida’s report for the fourth quarter 2021

Bravida’s report for the fourth quarter 2021 will be published 07:30 CET on 15 February 2022.The report will be presented at 09:30 CET by CEO and Group President Mattias Johansson and CFO Åsa Neving. The presentation will be held in English and can be followed on the web or on the phone. There will be room for questions in the telephone conference. Link to webcasthttps://tv.streamfabriken.com/bravida-q4-2021 Telephone conference dial-in numberSE:  +46850558352 UK:  +443333009264 US:  +16467224956 The report and presentation will be available on www.bravida.se/en/investors

Attendo's year-end report for 2021 to be published on 10 February 2022 - Invitation to teleconference

On 10 February around 08:00 am (CET), Attendo will present its year-end report and fourth quarter results for 2021. Investors and analysts are invited to participate in a teleconference at 10:00 am (CET) on the same date.The teleconference will be hosted by Attendo’s CEO Martin Tivéus and CFO Fredrik Lagercrantz. The presentation will be held in English. Date:                 10 February 2022Time:                 10:00 am (CET) To participate in the conference, please dial in on any number below at least ten minutes before the start of the call: SE:                      +46 8 505

The nomination committee’s proposal of board of directors in ADDvise Group AB (publ)

To the annual general Meeting (AGM) of ADDvise Group AB (publ) on 6 May 2022, the nomination committee has decided to propose re-election of Fredrik Celsing, Staffan Torstensson, Erland Pontusson and Johanne Brændgaard as members of the board of directors. In addition, the nomination committee proposes the election of Anna Ljung. It is proposed that Staffan Torstensson is re-elected chairman of the board of directors. Rikard Akhtarzand, CEO of the company, has declined re-election to separate the roles of CEO and board member, since one of the board’s tasks, amongst others, is to evaluate

Smartoptics Group AS (SMOP): Invitation to presentation of results for the fourth quarter 2021

Oslo, Norway – 4 February 2022 - Smartoptics Group AS will publish its financial results for the fourth quarter on Friday the 11[th] of February 2022, at 06:00 CET. The company will host a presentation of the results by CEO Magnus Grenfeldt and CFO Mikael Haag on the same day at 08:00 CET at Hotel Continental in Oslo. The presentation will also be sent live via webcast.Date: Friday 11 February 2022Time: 08:00 CETVenue: Hotel Continental, Stortingsgaten 24/26, OsloLanguage: EnglishWebcast link: https://channel.royalcast.com/landingpage/hegnarmedia/20220211_1/ The report and

Invitation to Ferronordic’s investor presentation 18 February 2022

Ferronordic’s year-end report of 2021 will be published on 18 February 2022 at 07:30 CET. A presentation of the report will be held the same day at 10:00 CET.Ferronordic’s year-end report for 2021 will be published on 18 February 2021 at 07.30 CET and will be accessible at www.ferronordic.com. Ferronordic invites investors, analysts and the media to a presentation where Lars Corneliusson, CEO, and Erik Danemar, CFO, comment on the report. The presentation will be held on 18 February 2022 at 10:00 CET and can be followed via telephone conference or audiocast. The presentation

Invitation to presentation of Quickbit’s Q2 ‘21/22 interim report

Quickbit will publish its interim report for the period 1 October – 31 December 2021 on Wednesday, 9 February 2022, at 08:00 am CET. On the same day at 11:00 am CET Quickbit will organize a conference call with web presentation for analysts and investors. Hammad Abuiseifan, CEO, and Simon Afeworki, CFO, will present and comment on the report. After the presentation there will be time for questions, both on the phone and in the web presentation. The presentation will be held in English. The live webcast will be available at https://tv.streamfabriken.com/quickbit-interim-q2-2021

Invitation to Medicover’s results presentation for Q4 2021

Medicover’s (MCOV B ) year-end and Q4 report 2021 will be published on 11 February at 07.45 CET. The Company will hold a conference call (in English) for media, financial analysts and investors at 09.30 CET. The report will be presented by CEO Fredrik Rågmark and CFO Joe Ryan and followed by a question-and-answer session. Shortly before the webcast, presentation slides will be available on medicover.com . To join the conference call please dial-in using the following details at least 10 minutes before the

Invitation to presentation of Eastnine's Year-end Report 2021

Eastnine's Year-End Report will be published on Friday, February 11, 2022, at 7.00 (CET). The report is presented at a webcast the same day by Kestutis Sasnauskas, CEO and Britt-Marie Nyman, CFO and Deputy CEO. Time for the webcast Friday February 11 2022, 09.15 (CET) Please join the event a few minutes before the presentation begins. An investor presentation will be available at www.eastnine.com 15 minutes before the start of the webcast. Click here  to see the webcast. A recording of the webcast will also be available afterward on the

CEO of CISH AB to present at Aktiespararna's Sustainable Investments Day on Monday, 07 February 2022

Christian Zahler, CEO of Clean Industry Solutions Holding Europe AB, will attend the Sustainable Investments Day (Hållbara investeringar dag) hosted by Aktiespararna to inform shareholders. The event highlights how investments can help companies like Clean Industry Solutions make the world a better place.The presentation takes place at 18:00 (CET). Christian Zahler will inform you about the company’s latest developments and talk about how investments can change the industry and support clean energy solutions. Stream the event live atwww.aktiespararna.se/tv/live For further

Invitation to Immunovia’s Q4 presentation

LUND (SWEDEN) – Immunovia will publish its full year 2021 results on 17 February 2022 at 08:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 10:00 am CET. The report together with the presentation slides will be available at www.immunovia.com   Philipp Mathieu, Acting CEO and President, will present on Immunovia’s development. The presentation will be held in English and be followed by a Q&A session. You are welcome to join via webcast or phone, see details below.   Telephone numbers and webcast Ring any of the numbers below

Inzile expands sales together with NT Maskin

NT Maskin AB, based in Enköping and Sala, operates in the Swedish regions Mälardalen, Dalarna and Värmland. It is an entrepreneurial company with extensive experience in sales in the green space and contracting industry. - We notice that there is an increasing demand for work vehicles with battery operation in our industry, and we are therefore pleased to offer our customers Inzile's Swedish-made quality vehicles, says Nina Wisell, CEO of NT Maskin. - Inzile is looking forward to the collaboration with Nina Wisell and NT Maskin, says Carsten Jörgensen, Sales Manager at Inzile. Their

Statement: John Butler, President & CEO of the World Shipping Council on the Senate Ocean Shipping Reform Act

Washington, February 4 – The World Shipping Council (WSC) notes that the Senate has now introduced its own bill, the Ocean Shipping Reform Act, to amend the Shipping Act.“Ocean carriers continue to work with all members of the supply chain, the Federal Maritime Commission, the administration, and their customers to identify and implement operational solutions to mitigate the ongoing supply chain congestion. Ocean carriers have deployed every available ship and container to move the continuing record levels of cargo resulting from pandemic-driven U.S. demand for imports—but when ships cannot

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 31 - 4 FEBRUARY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

Publishing of Qt Group’s Financial Statement Bulletin and Annual Report 2021 on February 17, 2022

Qt Group Plc, press release, February 4, 2022 at 10.00 am EETThe Qt Group Plc will publish its Financial statement bulletin for January 1 – December 31, 2021 on Thursday February 17, 2022 at 8:00 am EET. The report will be available after publishing at www.qt.io/investors Annual Report 2021, which includes the report of the Board of Directors, consolidated and parent company financial statements, Corporate Governance Statement and the remuneration report will be published on the same day at 8:00 am EET. The Annual Report will be available after publishing at www.qt.io/investors News

Cantargia reports treatment of first non-squamous non-small cell lung cancer patient in new arm of CANFOUR study

Cantargia AB today reported that the first patient in the new non-squamous non-small cell lung cancer (NSCLC) therapy arm of the CANFOUR study has received treatment with nadunolimab and chemotherapy. Interim clinical data has shown encouraging efficacy in patients with non-squamous histology, the largest NSCLC subgroup. Up to 40 patients will be treated with nadunolimab and carboplatin/pemetrexed and recruitment is expected to take 12-15 months. In parallel, preparations are ongoing for a randomized trial in this patient group with an anticipated start in early 2023.Nadunolimab, an

Invitation to presentation of Balco’s fourth quarter report 2021

Balco’s interim report for the fourth quarter 2021 will be published at 07:30 CET on February 17, 2021. A web-cast telephone conference will be held at 09:00 CET the same day, where CEO and President Kenneth Lundahl and CFO Michael Grindborn will present the results for the fourth quarter 2021.A possibility will be given to ask questions via the webcast and follow the presentation material live. The webcast, which afterwards also will be available on demand, will be accessible at Balco’s financial website, https://balcogroup.se or via the following link: https://tv.streamfabriken.com/balco-

Kindred continues its engagement with #AuCoeurDuFootball

Kindred’s sportsbook brand Unibet, will continue to sponsor 300 amateur football clubs in France through the #AuCoeurDuFootball program. This will mark the fourth season of Unibet donating jersey kits to the players and clothes to the volunteers at the clubs in the amateur leagues, among other contributions.Kindred Group plc (Kindred) has been supporting amateur football in France since 2019 and will continue their support in 2022. On top of the 10,000 kits with jerseys, shorts and socks for the players and clothes for the clubs’ volunteers, Unibet will also support the clubs with a digital

Contract awards for CSVs

Solstad Offshore ASA ("Solstad") is pleased to announce awards of multiple contracts involving several of its subsea vessels (CSV). The contracts have a combined firm utilization of 640 days, with additional options thereafter, on projects in the North Sea, Brazil and West Africa. The contracts, that have a combined value of approximately NOK 400 million, including additional services, will be executed during 2022 by Solstads CSVs Normand Maximus, Normand Frontier, Normand Pioneer and Normand Navigator. The marked for subsea construction vessel continue to improve with strong demand

BioStock: Aptahem recruits to key positions before clinical studies

Aptahem has recently recruited to fill three key positions ahead of the phase I studies planned with sepsis candidate Apta-1. Karin Aschan is the company’s new Regulatory Affairs Director, while Maria Ekblad takes the position as new Chief Operating Officer. Thomas Rupp expands his involvement in Aptahem and assumes the role of CMC Director in the company. BioStock contacted CEO Mikael Lindstam for a brief comment on the timing of the recruitments, and what the agenda for 2022 looks like.Read the full interview with Mikael Lindstam at biostock.se: https://www.biostock.se/en/2022/02/

BioStock: Chordate enters 2022 with strong confidence

During 2021, Chordate Medical were able to ensure that several important pieces fell into place, such as the CE marking which allowed K.O.S to be marketed as a migraine treatment in the EU. Chordate is now looking forward to another eventful year that will include a list change to First North Growth Market and completion of the company’s migraine study. BioStock contacted CEO Anders Weilandt for a comment.Read the full article at biostock.se: https://www.biostock.se/en/2022/02/chordate-enters-2022-with-strong-confidence/ This is a press release from BioStock - Connecting Innovation &

Isofol recognizes World Cancer Day on February 4

Today, February 4, is World Cancer Day , and we at Isofol are sending our thoughts to those affected by advanced colorectal cancer – the third most common and the second deadliest type of cancer.Our CEO Ulf Jungnelius, a Medical Oncologist by training and experienced researcher, made the following statement in recognition of World Cancer Day: – World Cancer Day is an important time to reflect on how we as an oncology company can and should drive the evolution of cancer detection, diagnosis, treatment and care. Ulf Jungnelius recently participated in

Flowscape's smart office solution wins deal in Switzerland

Flowscape is growing in the DACH region with its market-leading solution for the new hybrid way of working . The order value for the first year is 15,000 Euros (156,000 SEK) and then 10,800 Euros (112,100 SEK) in annually recurring SaaS revenue"The demand for smart solutions for the new hybrid way of working is global. Now we are growing further in Europe, this time in Switzerland with an installation for a world-leading medical technology company. Together with one of our partners in the region, the customer has chosen Flowscape as the best supplier for

Scandion Oncology announces share purchase by member of management

Scandion Oncology A/S, the Cancer Drug Resistance Company, today announced that a member of management discharging managerial responsibilities has purchased shares in the company.The company’s Chief Operating Officer, Maj Hedtjärn has reported that she has bought 8,000 shares in December 2021. This brings her total shareholding up to 24,000 shares. Persons under an obligation to report are persons discharging managerial responsibilities, as well as persons closely associated with them. For further information please contact: Mads Kronborg, Head of External Communication Phone:

Swedbank Robur increases the collaboration with Folksam Group

Swedbank Robur and Folksam has since 2007 worked closely together in investment management, administration and reporting regarding Folksam Group's portfolios. Swedbank Robur and Folksam are now increasing their cooperation and have entered into a strategic partnership for the continued development of investment management solutions and related services."Business and product development in close cooperation with our customers is an important part of continuously developing our offering to all customers. With this partnership, we are taking the cooperation with our largest customer Folksam to

There are no items matching the current filter
There are no more items matching the current filter
Back to top